Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Adult, Biological, HSCs, antibodies, viral, bioengineering, Diseases, Therapies, GVHD, cell regulation, Pediatric, Biological Processes, white blood cells, Technology and Procedures, cell expansion, Immune Disorders, immune cells, epigenetics, Cell Lineage, Infectious Diseases, Lymphoid Malignancies, Study Population, gene editing, Clinically relevant, genetic profiling, genomics, Myeloid Malignancies, transplantation, immune mechanism, flow cytometry, molecular testing, serologic tests, pathogenesis
Type: Oral
Hematology Disease Topics & Pathways:
Adult, Biological, HSCs, antibodies, viral, bioengineering, Diseases, Therapies, GVHD, cell regulation, Pediatric, Biological Processes, white blood cells, Technology and Procedures, cell expansion, Immune Disorders, immune cells, epigenetics, Cell Lineage, Infectious Diseases, Lymphoid Malignancies, Study Population, gene editing, Clinically relevant, genetic profiling, genomics, Myeloid Malignancies, transplantation, immune mechanism, flow cytometry, molecular testing, serologic tests, pathogenesis
Sunday, December 6, 2020: 12:00 PM-1:30 PM
Moderators:
Brian G. Engelhardt, MD, Vanderbilt University Medical Center
and
Joseph Pidala, MD, H. Lee Moffitt Cancer Center and Research Institute
Disclosures:
Pidala: Syndax: Consultancy, Membership on an entity's Board of Directors or advisory committees; CTI Biopharma: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; Amgen: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; Novartis: Research Funding; Takeda: Research Funding; Janssen: Research Funding; Johnson and Johnson: Research Funding; Pharmacyclics: Research Funding; Abbvie: Research Funding; BMS: Research Funding.
12:00 PM
12:15 PM
12:45 PM
1:00 PM
1:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH